Last reviewed · How we verify
Non-racemic mixture of methadone HCl
Non-racemic mixture of methadone HCl is a Small molecule drug developed by MetaPharm, Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | Non-racemic mixture of methadone HCl |
|---|---|
| Sponsor | MetaPharm, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Non-racemic mixture of methadone HCl CI brief — competitive landscape report
- Non-racemic mixture of methadone HCl updates RSS · CI watch RSS
- MetaPharm, Inc. portfolio CI
Frequently asked questions about Non-racemic mixture of methadone HCl
What is Non-racemic mixture of methadone HCl?
Non-racemic mixture of methadone HCl is a Small molecule drug developed by MetaPharm, Inc..
Who makes Non-racemic mixture of methadone HCl?
Non-racemic mixture of methadone HCl is developed by MetaPharm, Inc. (see full MetaPharm, Inc. pipeline at /company/metapharm-inc).
What development phase is Non-racemic mixture of methadone HCl in?
Non-racemic mixture of methadone HCl is in Phase 2.